TALLINN – The European Commission has presented a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19 and, in order to support companies in the swift development and production of a vaccine, the Commission will enter into advance purchase agreements in the extent of 2.7 billion euros with individual vaccine producers on behalf of the member states.
In order to support companies in the swift development and production of a vaccine, the Commission will enter into agreements with individual vaccine producers on beh...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our SUBSCRIPTION